Related Experiment Videos
Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53
C Venot1, M Maratrat, V Sierra
1Centre de Recherche de Vitry-Alfortville, Rhône-Poulenc Rorer, Vitry sur Seine, France.
Abstract:
The wild-type protein product of the p53 tumor suppressor gene can activate transcription of genes which are involved in mediating either growth arrest, e.g. WAF1 or apoptotis, e.g. BAX and PICG3. Additionally, p53 can repress a variety of promoters, which, in turn, may be responsible for the functional activities exhibited by p53. This study shows that the Q22, S23 double mutation, which is known to inactivate a p53 transactivation subdomain located within the initial 40 residues of the protein, while abrogating transactivation from the WAF1 promoter, only attenuates apoptosis triggering, transactivation from other p53-responsive promoters and repression of promoters by p53. The Q53, S54 double mutation, which inactivates another p53 transactivation subdomain situated between amino acids 43 and 73 results in attenuation of all of the aforementioned p53 activities. In contrast to the Q22, S23 double mutation, this latter mutation set does not alter mdm-2-mediated inhibition and degradation of p53. Finally, mutation of all four residues results in complete abrogation of every p53 activity mentioned above.
Insights
Mutations in the p53 tumor suppressor gene impact its ability to regulate gene transcription. Specific mutations differentially affect p53
Area of Science:
- Molecular Biology
- Cancer Genetics
- Tumor Suppressor Genes
Background:
- The p53 tumor suppressor protein regulates genes involved in cell cycle arrest and apoptosis.
- p53's transcriptional activation and repression functions are critical for its tumor-suppressive activity.
- Specific domains within p53 mediate its diverse transcriptional functions.
Purpose of the Study:
- To investigate the functional consequences of mutations in p53 transactivation subdomains.
- To determine how specific p53 mutations affect transactivation, apoptosis induction, and promoter repression.
- To analyze the impact of mutations on p53 stability and mdm-2 mediated regulation.
Main Methods:
- Site-directed mutagenesis to create specific p53 mutations (Q22, S23; Q53, S54).
- Reporter gene assays to measure transactivation from p53-responsive promoters (WAF1, BAX, PICG3).
- Assessment of p53-mediated promoter repression.
- Analysis of mdm-2-mediated inhibition and degradation of p53.
Main Results:
- The Q22, S23 mutation abrogated WAF1 transactivation but only attenuated apoptosis, other transactivation, and repression.
- The Q53, S54 mutation attenuated all tested p53 activities and did not affect mdm-2 mediated inhibition/degradation.
- Mutation of all four residues completely abolished all tested p53 activities.
Conclusions:
- p53 transactivation subdomains play distinct roles in mediating its various functions.
- Mutations within these subdomains differentially impact p53's ability to regulate gene expression and apoptosis.
- Understanding these structure-function relationships is crucial for p53-targeted cancer therapies.